138 related articles for article (PubMed ID: 18617646)
1. Brief report: accelerated atherosclerosis in low-density lipoprotein receptor-deficient mice lacking the membrane-bound complement regulator CD59.
Yun S; Leung VW; Botto M; Boyle JJ; Haskard DO
Arterioscler Thromb Vasc Biol; 2008 Oct; 28(10):1714-6. PubMed ID: 18617646
[TBL] [Abstract][Full Text] [Related]
2. Decay-accelerating factor suppresses complement C3 activation and retards atherosclerosis in low-density lipoprotein receptor-deficient mice.
Leung VW; Yun S; Botto M; Mason JC; Malik TH; Song W; Paixao-Cavalcante D; Pickering MC; Boyle JJ; Haskard DO
Am J Pathol; 2009 Oct; 175(4):1757-67. PubMed ID: 19729477
[TBL] [Abstract][Full Text] [Related]
3. Deficiency of the complement regulatory protein CD59 accelerates the development of diabetes-induced atherosclerosis in mice.
Liu F; Sahoo R; Ge X; Wu L; Ghosh P; Qin X; Halperin JA
J Diabetes Complications; 2017 Feb; 31(2):311-317. PubMed ID: 27729184
[TBL] [Abstract][Full Text] [Related]
4. The membrane attack complex of complement drives the progression of atherosclerosis in apolipoprotein E knockout mice.
Lewis RD; Jackson CL; Morgan BP; Hughes TR
Mol Immunol; 2010 Feb; 47(5):1098-105. PubMed ID: 19959238
[TBL] [Abstract][Full Text] [Related]
5. Complement regulator CD59 protects against atherosclerosis by restricting the formation of complement membrane attack complex.
Wu G; Hu W; Shahsafaei A; Song W; Dobarro M; Sukhova GK; Bronson RR; Shi GP; Rother RP; Halperin JA; Qin X
Circ Res; 2009 Feb; 104(4):550-8. PubMed ID: 19131645
[TBL] [Abstract][Full Text] [Related]
6. CD59 but not DAF deficiency accelerates atherosclerosis in female ApoE knockout mice.
An G; Miwa T; Song WL; Lawson JA; Rader DJ; Zhang Y; Song WC
Mol Immunol; 2009 May; 46(8-9):1702-9. PubMed ID: 19297024
[TBL] [Abstract][Full Text] [Related]
7. Complement C1q reduces early atherosclerosis in low-density lipoprotein receptor-deficient mice.
Bhatia VK; Yun S; Leung V; Grimsditch DC; Benson GM; Botto MB; Boyle JJ; Haskard DO
Am J Pathol; 2007 Jan; 170(1):416-26. PubMed ID: 17200212
[TBL] [Abstract][Full Text] [Related]
8. The alternative pathway is critical for pathogenic complement activation in endotoxin- and diet-induced atherosclerosis in low-density lipoprotein receptor-deficient mice.
Malik TH; Cortini A; Carassiti D; Boyle JJ; Haskard DO; Botto M
Circulation; 2010 Nov; 122(19):1948-56. PubMed ID: 20974996
[TBL] [Abstract][Full Text] [Related]
9. Discoidin domain receptor 1 (ddr1) deletion decreases atherosclerosis by accelerating matrix accumulation and reducing inflammation in low-density lipoprotein receptor-deficient mice.
Franco C; Hou G; Ahmad PJ; Fu EY; Koh L; Vogel WF; Bendeck MP
Circ Res; 2008 May; 102(10):1202-11. PubMed ID: 18451340
[TBL] [Abstract][Full Text] [Related]
10. Distinct roles for complement in glomerulonephritis and atherosclerosis revealed in mice with a combination of lupus and hyperlipidemia.
Lewis MJ; Malik TH; Fossati-Jimack L; Carassiti D; Cook HT; Haskard DO; Botto M
Arthritis Rheum; 2012 Aug; 64(8):2707-18. PubMed ID: 22392450
[TBL] [Abstract][Full Text] [Related]
11. No effect of C-reactive protein on early atherosclerosis in LDLR-/- / human C-reactive protein transgenic mice.
Torzewski M; Reifenberg K; Cheng F; Wiese E; Küpper I; Crain J; Lackner KJ; Bhakdi S
Thromb Haemost; 2008 Jan; 99(1):196-201. PubMed ID: 18217154
[TBL] [Abstract][Full Text] [Related]
12. Genetic Deletion of IL-19 (Interleukin-19) Exacerbates Atherogenesis in
Ray M; Gabunia K; Vrakas CN; Herman AB; Kako F; Kelemen SE; Grisanti LA; Autieri MV
Arterioscler Thromb Vasc Biol; 2018 Jun; 38(6):1297-1308. PubMed ID: 29674474
[TBL] [Abstract][Full Text] [Related]
13. Immunoglobulin M is required for protection against atherosclerosis in low-density lipoprotein receptor-deficient mice.
Lewis MJ; Malik TH; Ehrenstein MR; Boyle JJ; Botto M; Haskard DO
Circulation; 2009 Aug; 120(5):417-26. PubMed ID: 19620499
[TBL] [Abstract][Full Text] [Related]
14. Nuclear factor E2-related factor 2 deficiency impairs atherosclerotic lesion development but promotes features of plaque instability in hypercholesterolaemic mice.
Ruotsalainen AK; Lappalainen JP; Heiskanen E; Merentie M; Sihvola V; Näpänkangas J; Lottonen-Raikaslehto L; Kansanen E; Adinolfi S; Kaarniranta K; Ylä-Herttuala S; Jauhiainen M; Pirinen E; Levonen AL
Cardiovasc Res; 2019 Jan; 115(1):243-254. PubMed ID: 29917052
[TBL] [Abstract][Full Text] [Related]
15. Bone marrow-specific caspase-1/11 deficiency inhibits atherosclerosis development in Ldlr(-/-) mice.
Hendrikx T; Jeurissen ML; van Gorp PJ; Gijbels MJ; Walenbergh SM; Houben T; van Gorp R; Pöttgens CC; Stienstra R; Netea MG; Hofker MH; Donners MM; Shiri-Sverdlov R
FEBS J; 2015 Jun; 282(12):2327-38. PubMed ID: 25817537
[TBL] [Abstract][Full Text] [Related]
16. RAGE mediates oxidized LDL-induced pro-inflammatory effects and atherosclerosis in non-diabetic LDL receptor-deficient mice.
Sun L; Ishida T; Yasuda T; Kojima Y; Honjo T; Yamamoto Y; Yamamoto H; Ishibashi S; Hirata K; Hayashi Y
Cardiovasc Res; 2009 May; 82(2):371-81. PubMed ID: 19176597
[TBL] [Abstract][Full Text] [Related]
17. Deficiency of HIF1α in Antigen-Presenting Cells Aggravates Atherosclerosis and Type 1 T-Helper Cell Responses in Mice.
Chaudhari SM; Sluimer JC; Koch M; Theelen TL; Manthey HD; Busch M; Caballero-Franco C; Vogel F; Cochain C; Pelisek J; Daemen MJ; Lutz MB; Görlach A; Kissler S; Hermanns HM; Zernecke A
Arterioscler Thromb Vasc Biol; 2015 Nov; 35(11):2316-25. PubMed ID: 26404487
[TBL] [Abstract][Full Text] [Related]
18. Loss of Transcription Factor CREBH Accelerates Diet-Induced Atherosclerosis in Ldlr-/- Mice.
Park JG; Xu X; Cho S; Lee AH
Arterioscler Thromb Vasc Biol; 2016 Sep; 36(9):1772-81. PubMed ID: 27417587
[TBL] [Abstract][Full Text] [Related]
19. Cathepsin L deficiency reduces diet-induced atherosclerosis in low-density lipoprotein receptor-knockout mice.
Kitamoto S; Sukhova GK; Sun J; Yang M; Libby P; Love V; Duramad P; Sun C; Zhang Y; Yang X; Peters C; Shi GP
Circulation; 2007 Apr; 115(15):2065-75. PubMed ID: 17404153
[TBL] [Abstract][Full Text] [Related]
20. PAR2 (Protease-Activated Receptor 2) Deficiency Attenuates Atherosclerosis in Mice.
Jones SM; Mann A; Conrad K; Saum K; Hall DE; McKinney LM; Robbins N; Thompson J; Peairs AD; Camerer E; Rayner KJ; Tranter M; Mackman N; Owens AP
Arterioscler Thromb Vasc Biol; 2018 Jun; 38(6):1271-1282. PubMed ID: 29599135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
